In addition to its effects on cancer cells, rhamnetin suppresses the production of pro-inflammatory cytokines and mediators in mouse macrophages by acting on the p38 MAPK, ERK, JNK, and COX-2 pathways. This evidence concerns the gene MAPK8 and cancer.